Lian, Zhe-Xiong

Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation

Wang, J., Li, F., Wei, H., Lian, Z.-X., Sun, R., & Tian, Z. (2014) · Journal of Experimental Medicine

Influenza Virus Research StudiesGut microbiota and health

Cited by 490

IL-2 receptor α−/− mice and the development of primary biliary cirrhosis

Wakabayashi, K., Lian, Z.-X., Moritoki, Y., Lan, R. Y., Tsuneyama, K., Chuang, Y.-H., Yang, G.-X., Ridgway, W., Ueno, Y., Ansari, A. A., et al. (2006) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 233

Quantitative and functional analysis of PDC‐E2‐specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis

Kita, H., Matsumura, S., He, X.-S., Ansari, A. A., Lian, Z.-X., Van de Water, J., Coppel, R. L., Kaplan, M. M., & Gershwin, M. E. (2002) · Journal of Clinical Investigation

Liver Diseases and ImmunityT-cell and B-cell Immunology

Cited by 222

Hepatic IL-17 responses in human and murine primary biliary cirrhosis

Lan, R. Y. Z., Salunga, T. L., Tsuneyama, K., Lian, Z.-X., Yang, G.-X., Hsu, W., Moritoki, Y., Ansari, A. A., Kemper, C., Price, J., et al. (2009) · Journal of Autoimmunity

Liver Diseases and ImmunityT-cell and B-cell Immunology

Cited by 202

Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride #

Park, O., Jeong, W.-I., Wang, L., Wang, H., Lian, Z.-X., Gershwin, E. M., & Gao, B. (2009) · Hepatology

Liver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

Cited by 189

Altered Monocyte Responses to Defined TLR Ligands in Patients With Primary Biliary Cirrhosis *

Mao, T. K., Lian, Z.-X., Selmi, C., Ichiki, Y., Ashwood, P., Ansari, A. A., Coppel, R. L., Shimoda, S., Ishibashi, H., & Gershwin, E. M. (2005) · Hepatology

Liver Diseases and ImmunityImmune Response and Inflammation

Cited by 185

Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis

Chuang, Y.-H., Lian, Z.-X., Tsuneyama, K., Chiang, B.-L., Ansari, A. A., Coppel, R. L., & Eric Gershwin, M. (2006) · Journal of Autoimmunity

Liver Diseases and ImmunityImmune Cell Function and Interaction

Cited by 121

The challenges of primary biliary cholangitis: What is new and what needs to be done

Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 114

Aurora A inhibition eliminates myeloid cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in breast cancer

Yin, T., Zhao, Z.-B., Guo, J., Wang, T., Yang, J.-B., Wang, C., Long, J., Ma, S., Huang, Q., Zhang, K., et al. (2019) · Cancer Research

Immune cells in cancerCancer Immunotherapy and Biomarkers

Cited by 92

Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody–positive versus antimitochondrial autoantibody–negative primary biliary cirrhosis

Jin, Q., Moritoki, Y., Lleo, A., Tsuneyama, K., Invernizzi, P., Moritoki, H., Kikuchi, K., Lian, Z.-X., Hirschfield, G. M., Ansari, A. A., et al. (2012) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 37